The Current Ratio as of September 2024 (TTM) for IO Biotech, Inc. (IOBT) is 7.84

According to IO Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.84. This represents a change of -24.23% compared to the average of 10.35 of the last 4 quarters.

IO Biotech, Inc. (IOBT) Historical Current Ratio (quarterly & annually)

How has IOBT Current Ratio performed in the past?

The mean historical Current Ratio of IO Biotech, Inc. over the last ten years is 9.50. The current 7.84 Current Ratio has changed 8.16% with respect to the historical average. Over the past ten years (40 quarters), IOBT's Current Ratio was at its highest in in the March 2022 quarter at 30.99. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

IO Biotech, Inc. (IOBT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IO Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IO Biotech, Inc. (IOBT) Average Current Ratio

How has IOBT Current Ratio performed in the past?

The current Current Ratio of IO Biotech, Inc. (IOBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IO Biotech, Inc. (IOBT) Current Ratio vs. Peers

How is IOBT’s Current Ratio compared to its peers?

IO Biotech, Inc.’s Current Ratio is less than PMV Pharmaceuticals, Inc. (19.22), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (18.24), less than Pharvaris N.V. (18.45), greater than PepGen Inc. (7.45), less than Pardes Biosciences, Inc. (81.72), greater than Shattuck Labs, Inc. (7.62), greater than Champions Oncology, Inc. (0.69), less than Century Therapeutics, Inc. (10.62), less than Structure Therapeutics Inc. (41.38), less than Erasca, Inc. (16.79), greater than ASLAN Pharmaceuticals Limited (1.05), greater than Lyra Therapeutics, Inc. (3.60), greater than Monte Rosa Therapeutics, Inc. (6.56), less than NewAmsterdam Pharma Company N.V. (9.83), greater than Inventiva S.A. (0.95), less than Cullinan Oncology, Inc. (28.87), less than Compass Therapeutics, Inc. (40.74), less than Design Therapeutics, Inc. (41.42), less than Werewolf Therapeutics, Inc. (12.13), less than Ikena Oncology, Inc. (18.22), greater than Stoke Therapeutics, Inc. (6.67),

Build a custom stock screener for IO Biotech, Inc. (IOBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IO Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IO Biotech, Inc. (IOBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IO Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.